31/03/2018
2018-03-31
false
false
false
false
false
false
false
false
false
false
true
false
false
true
false
false
false
false
false
false
false
false
No description of principal activities is disclosed
2017-04-01
Sage Accounts Production 18.30 - FRS
xbrli:pure
xbrli:shares
iso4217:GBP
09883961
2017-04-01
2018-03-31
09883961
2018-03-31
09883961
2017-03-31
09883961
2016-04-01
2017-03-31
09883961
2017-03-31
09883961
core:LandBuildings
core:ShortLeaseholdAssets
2017-04-01
2018-03-31
09883961
bus:RegisteredOffice
2017-04-01
2018-03-31
09883961
bus:LeadAgentIfApplicable
2017-04-01
2018-03-31
09883961
bus:Director1
2017-04-01
2018-03-31
09883961
bus:Director2
2017-04-01
2018-03-31
09883961
core:FurnitureFittingsToolsEquipment
2018-03-31
09883961
core:ShareCapital
2016-04-01
2017-03-31
09883961
core:RetainedEarningsAccumulatedLosses
2016-04-01
2017-03-31
09883961
core:RetainedEarningsAccumulatedLosses
2017-04-01
2018-03-31
09883961
core:WithinOneYear
2018-03-31
09883961
core:WithinOneYear
2017-03-31
09883961
core:ShareCapital
2018-03-31
09883961
core:ShareCapital
2017-03-31
09883961
core:RetainedEarningsAccumulatedLosses
2018-03-31
09883961
core:RetainedEarningsAccumulatedLosses
2017-03-31
09883961
core:FurnitureFittingsToolsEquipment
2017-04-01
2018-03-31
09883961
bus:Director1
2017-03-31
09883961
bus:Director1
2018-03-31
09883961
bus:Director2
2017-03-31
09883961
bus:Director2
2018-03-31
09883961
bus:Director1
2017-03-31
09883961
bus:Director2
2017-03-31
09883961
bus:Director1
2016-04-01
2017-03-31
09883961
bus:Director2
2016-04-01
2017-03-31
09883961
bus:SmallEntities
2017-04-01
2018-03-31
09883961
bus:AuditExemptWithAccountantsReport
2017-04-01
2018-03-31
09883961
bus:FullAccounts
2017-04-01
2018-03-31
09883961
bus:SmallCompaniesRegimeForAccounts
2017-04-01
2018-03-31
09883961
bus:PrivateLimitedCompanyLtd
2017-04-01
2018-03-31
Company registration number:
09883961
Ophthalmic Market Access Ltd
Unaudited filleted financial statements
31 March 2018
Ophthalmic Market Access Ltd
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Ophthalmic Market Access Ltd
Directors and other information
|
|
|
|
Directors
|
Mr Ian Grierson
|
|
|
Mrs Elizabeth Angela Reidy
|
|
|
|
|
|
|
|
Company number
|
09883961
|
|
|
|
|
|
|
|
Registered office
|
113 Wallasey Road
|
|
|
Wallasey
|
|
|
CH44 2AA
|
|
|
|
|
|
|
|
Business address
|
14 York Road
|
|
|
Birkdale
|
|
|
Southport
|
|
|
Merseyside
|
|
|
PR8 2AD
|
|
|
|
|
|
|
|
Accountants
|
Taylor PhelanLtd
|
|
|
113 Wallasey Road
|
|
|
Wallasey
|
|
|
Wirral
|
|
|
CH44 2AA
|
|
|
|
Ophthalmic Market Access Ltd
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Ophthalmic Market Access Ltd
Year ended 31 March 2018
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ophthalmic Market Access Ltd for the year ended 31 March 2018 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global /Technical/fact/technical-factsheet-163.pdf.
Taylor PhelanLtd
Chartered Certified Accountant
113 Wallasey Road
Wallasey
Wirral
CH44 2AA
27 November 2018
Ophthalmic Market Access Ltd
Statement of financial position
31 March 2018
|
|
|
2018
|
|
|
|
2017
|
|
|
|
|
Note
|
£
|
|
£
|
|
£
|
|
£
|
|
|
|
|
|
|
|
|
|
|
Fixed assets
|
|
|
|
|
|
|
|
|
|
Tangible assets
|
|
4
|
464
|
|
|
|
-
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
464
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
|
Debtors
|
|
5
|
25,750
|
|
|
|
21,892
|
|
|
Investments
|
|
6
|
14,850
|
|
|
|
14,850
|
|
|
Cash at bank and in hand
|
|
|
16,007
|
|
|
|
19,264
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
56,607
|
|
|
|
56,006
|
|
|
Creditors: amounts falling due
|
|
|
|
|
|
|
|
|
|
within one year
|
|
7
|
(
31,301)
|
|
|
|
(
36,334)
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
Net current assets
|
|
|
|
|
25,306
|
|
|
|
19,672
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Total assets less current liabilities
|
|
|
|
|
25,770
|
|
|
|
19,672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Net assets
|
|
|
|
|
25,770
|
|
|
|
19,672
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
|
|
|
|
Called up share capital
|
|
|
|
|
2
|
|
|
|
2
|
Profit and loss account
|
|
|
|
|
25,768
|
|
|
|
19,670
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Shareholders funds
|
|
|
|
|
25,770
|
|
|
|
19,672
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
For the year ending 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
27 November 2018
, and are signed on behalf of the board by:
Mr Ian Grierson
Director
Company registration number:
09883961
Ophthalmic Market Access Ltd
Statement of changes in equity
Year ended 31 March 2018
|
|
Called up share capital
|
|
Profit and loss account
|
Total
|
|
|
|
|
|
|
|
£
|
|
£
|
£
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 April 2016
|
|
-
|
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the year
|
|
|
|
29,670
|
29,670
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total comprehensive income for the year
|
|
-
|
|
29,670
|
29,670
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of shares
|
|
2
|
|
|
2
|
|
|
|
|
|
Dividends paid and payable
|
|
|
|
(
10,000)
|
(
10,000)
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total investments by and distributions to owners
|
|
2
|
|
(
10,000)
|
(
9,998)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2017 and 1 April 2017
|
|
2
|
|
19,670
|
19,672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the year
|
|
|
|
16,098
|
16,098
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total comprehensive income for the year
|
|
-
|
|
16,098
|
16,098
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid and payable
|
|
|
|
(
10,000)
|
(
10,000)
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total investments by and distributions to owners
|
|
-
|
|
(
10,000)
|
(
10,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2018
|
|
2
|
|
25,768
|
25,770
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ophthalmic Market Access Ltd
Notes to the financial statements
Year ended 31 March 2018
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 113 Wallasey Road, Wallasey, CH44 2AA.
2.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
|
|
|
|
|
Short leasehold property
|
-
|
25 %
|
reducing balance
|
|
|
|
|
|
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
4.
Tangible assets
|
|
Fixtures, fittings and equipment
|
Total
|
|
|
|
|
|
|
|
£
|
£
|
|
|
|
|
|
|
Cost
|
|
|
|
|
|
|
|
|
At 1 April 2017
|
-
|
-
|
|
|
|
|
|
|
Additions
|
619
|
619
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
At 31 March 2018
|
619
|
619
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
Depreciation
|
|
|
|
|
|
|
|
|
At 1 April 2017
|
-
|
-
|
|
|
|
|
|
|
Charge for the year
|
155
|
155
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
At 31 March 2018
|
155
|
155
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
|
At 31 March 2018
|
464
|
464
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
At 31 March 2017
|
-
|
-
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.
Debtors
|
|
|
2018
|
2017
|
|
|
|
£
|
£
|
|
Trade debtors
|
|
25,750
|
21,892
|
|
|
|
_______
|
_______
|
|
|
|
|
|
6.
Investments
|
|
|
2018
|
2017
|
|
|
|
£
|
£
|
|
Polyphotonix Shares
|
|
14,850
|
14,850
|
|
|
|
_______
|
_______
|
|
|
|
|
|
7.
Creditors: amounts falling due within one year
|
|
|
2018
|
2017
|
|
|
|
£
|
£
|
|
Corporation tax
|
|
3,668
|
7,462
|
|
Other creditors
|
|
27,633
|
28,872
|
|
|
|
_______
|
_______
|
|
|
|
31,301
|
36,334
|
|
|
|
_______
|
_______
|
|
|
|
|
|
8.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
Balance brought forward
|
Advances /(credits) to the directors
|
Balance o/standing
|
|
|
|
|
|
£
|
£
|
£
|
|
|
|
|
Mr Ian Grierson
|
(
23,153)
|
1,275
|
(
21,878)
|
|
|
|
|
Mrs Elizabeth Angela Reidy
|
(
4,999)
|
-
|
(
4,999)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
(
28,152)
|
1,275
|
(
26,877)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
|
|
|
|
|
|
|
|
Balance brought forward
|
Advances /(credits) to the directors
|
Balance o/standing
|
|
|
|
|
|
£
|
£
|
£
|
|
|
|
|
Mr Ian Grierson
|
-
|
(
23,153)
|
(
23,153)
|
|
|
|
|
Mrs Elizabeth Angela Reidy
|
-
|
(
4,999)
|
(
4,999)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
-
|
(
28,152)
|
(
28,152)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|